These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8392888)

  • 21. Paraoxonase distribution in Caucasian males.
    Williams FM; Mutch E; Blain PG
    Chem Biol Interact; 1993 Jun; 87(1-3):155-60. PubMed ID: 8393737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
    Eckerson HW; Romson J; Wyte C; La Du BN
    Am J Hum Genet; 1983 Mar; 35(2):214-27. PubMed ID: 6301268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
    Simeon V; Pavković E
    Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.
    Furlong CE; Richter RJ; Seidel SL; Costa LG; Motulsky AG
    Anal Biochem; 1989 Aug; 180(2):242-7. PubMed ID: 2479288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of the human serum paraoxonase activity polymorphism.
    Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
    Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study.
    Moghtaderi A; Hashemi M; Dabiri S; Moazeni-Roodi A; Hosseini M
    Clin Biochem; 2011 Mar; 44(4):288-92. PubMed ID: 21167145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymorphism of human serum paraoxonase activity in childhood].
    Szabó I; Róna K; Czinner A; Gachályi B; Káldor A
    Orv Hetil; 1987 Mar; 128(12):631-3. PubMed ID: 3033577
    [No Abstract]   [Full Text] [Related]  

  • 29. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
    Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
    Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Number of loci responsible for the inheritance of high and low activity of paraoxonase.
    Nielsen A; Eiberg H; Mohr J
    Clin Genet; 1986 Mar; 29(3):216-21. PubMed ID: 3009059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ESD polymorphism in Norway.
    Olaisen B; Teisberg P; Jonassen R
    Hum Genet; 1976 Sep; 34(1):63-4. PubMed ID: 965006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of esterases in plasma from Ghanaian and British subjects.
    Williams FM; Nicholson EN; Woolhouse NW; Adjepon-Yamoah KK; Rawlins MD
    Eur J Clin Pharmacol; 1986; 31(4):485-9. PubMed ID: 3028817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.
    Mueller RF; Hornung S; Furlong CE; Anderson J; Giblett ER; Motulsky AG
    Am J Hum Genet; 1983 May; 35(3):393-408. PubMed ID: 6305189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interindividual variations in enzymes controlling organophosphate toxicity in man.
    Mutch E; Blain PG; Williams FM
    Hum Exp Toxicol; 1992 Mar; 11(2):109-16. PubMed ID: 1349216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase polymorphism in northwestern Indians.
    Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interethnic differences in the detoxification of organophosphates: the human serum paraoxonase polymorphism.
    Diepgen TL; Geldmacher-von Mallinckrodt M
    Arch Toxicol Suppl; 1986; 9():154-8. PubMed ID: 3028323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase polymorphism in rabbits.
    Zech R; Severin RM; Chemnitius JM; Nebendahl K
    Chem Biol Interact; 1999 May; 119-120():283-8. PubMed ID: 10421463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage times.
    Brackley M; Carro-Ciampi G; Stewart DJ; Lowden JA; Ray AK; Kalow W
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):65-78. PubMed ID: 6312517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on human serum paraoxonase/arylesterase.
    La Du BN; Adkins S; Kuo CL; Lipsig D
    Chem Biol Interact; 1993 Jun; 87(1-3):25-34. PubMed ID: 8393742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of serum paraoxon hydrolyzing activity in family and population samples.
    Ishimoto G; Uchida H; Tsuge A
    Nihon Hoigaku Zasshi; 1987 Aug; 41(4):347-50. PubMed ID: 2826857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.